The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism
Abstract
Interest in the topic of tumour metabolism has waxed and waned over the past century of cancer research. The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumour metabolism to the margins of cancer research. In recent years, interest has been renewed as it has become clear that many of the signalling pathways that are affected by genetic mutations and the tumour microenvironment have a profound effect on core metabolism, making this topic once again one of the most intense areas of research in cancer biology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One possible explanation for the observed difference between cSNVs and dbSNVs could be system-wide alterations in cancer cells, which are often characterized by increased replication stress, altered DNA repair mechanisms or changes in chromatin structure (85,86).”
From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [85]
In the citing paper
“Recent findings implicate TME in the induced metabolic rewiring in cancer cells (Cairns et al., 2011; Fiaschi and Chiarugi, 2012; Rattigan et al., 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Cairns et al., 2011
In the citing paper
“Unlike normal cells, which derive most of their energy from mitochondrial oxidative phosphorylation, cancer cells rely on aerobic glycolysis as their primary energy resource. This process is recognized as the “Warburg effect”21–23.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [22]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,016
Immune Response Regulation in the Tumor Microenvironment by Hypoxia
Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 155
ALDOA functions as an oncogene in the highly metastatic pancreatic cancer
Ji, S., Zhang, B., Liu, J., Qin, Y., Liang, C., Shi, S., Jin, K., Liang, D., Xu, W., Xu, H., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.054 · Cited by 153
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 159
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
Cheng, J., Huang, Y., Zhang, X., Yu, Y., Wu, S., Jiao, J., Tran, L. M., Zhang, W., Liu, R., Zhang, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15819-3 · Cited by 153
Zhao, Z., Dong, S., Liu, Y., Wang, J., Ba, L., Zhang, C., Cao, X., Wu, C., & Yang, P. (2022) · ACS Nano · doi:10.1021/acsnano.2c06646 · Cited by 151
Recent advances for enhanced photodynamic therapy: from new mechanisms to innovative strategies
Wang, X., Peng, J., Meng, C., & Feng, F. (2024) · Chemical Science · doi:10.1039/d3sc07006a · Cited by 160
Mitochondria and Cancer: A Growing Role in Apoptosis, Cancer Cell Metabolism and Dedifferentiation
Scatena, R. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_13 · Cited by 152
Rosa, V. D., Iommelli, F., Monti, M., Fonti, R., Votta, G., Stoppelli, M. P., & Vecchio, S. D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0375 · Cited by 152
The regulation of cellular metabolism by tumor suppressor p53
Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 154
Nakagawa, Y., Negishi, Y., Shimizu, M., Takahashi, M., Ichikawa, M., & Takahashi, H. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.07.003 · Cited by 149
Identification of proteomic signatures associated with lung cancer and COPD
Pastor, M. D., Nogal, A., Molina‐Pinelo, S., Melendez, R., Salinas, A. M., de la Peña, M. G., Martín‐Juan, J., Corral, J., García‐Carbonero, R., Carnero, A., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.04.037 · Cited by 150
Li, Q., Cao, L., Tian, Y., Zhang, P., Ding, C., Lu, W., Jia, C., Shao, C., Liu, W., Wang, D., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000752 · Cited by 153
RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
Jones, R. A., Robinson, T., Liu, J. C., Shrestha, M., Voisin, V., Ju, Y., Chung, P. E. D., Pellecchia, G., Fell, V. L., Bae, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81568 · Cited by 148
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Lio, C. J., Yuita, H., & Rao, A. (2019) · Blood · doi:10.1182/blood.2019791475 · Cited by 152
The metabolic landscape of lung cancer: New insights in a disturbed glucose metabolism
Vanhove, K., Graulus, G.-J., Mesotten, L., Thomeer, M., Derveaux, E., Noben, J.-P., Guedens, W., & Adriaensens, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01215 · Cited by 147
Dando, I., Donadelli, M., Costanzo, C., Dalla Pozza, E., D'Alessandro, A., Zolla, L., & Palmieri, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.151 · Cited by 128
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Gill, K. S., Fernandes, P., O’Donovan, T. R., McKenna, S. L., Doddakula, K., Power, D. G., Soden, D. M., & Forde, P. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.005 · Cited by 149
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Ippolito, L., Marini, A., Cavallini, L., Morandi, A., Pietrovito, L., Pintus, G., Giannoni, E., Schrader, T. H., Puhr, M., Chiarugi, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11301 · Cited by 149
Goji, T., Takahara, K., Negishi, M., & Katoh, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814392 · Cited by 150
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Jagušt, P., de Luxán‐Delgado, B., Parejo-Alonso, B., & Sancho, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00203 · Cited by 151
Overmyer, K. A., Thonusin, C., Qi, N., Burant, C., & Evans, C. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117232 · Cited by 147
PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells
Jiang, Y., Wang, Y., Wang, T., Hawke, D. H., Zheng, Y., Li, X., Zhou, Q., Majumder, S., Bi, E., Liu, D. X., et al. (2014) · Nature Communications · doi:10.1038/ncomms6566 · Cited by 150
Oh, S., Kim, H., Nam, K., & Shin, I. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.3.189 · Cited by 147
LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism
Shang, C., Wang, W. T., Liao, Y., Chen, Y., Liu, T., Du, Q., Huang, J., Liang, Y., Liu, J., Zhao, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2356 · Cited by 146
Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next‐Generation Therapeutics
Singh, N., Sherin, G. R., & Mugesh, G. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202301232 · Cited by 152
Ma, Y., Wang, W., Idowu, M. O., Oh, U., Wang, X.-Y., Temkin, S. M., & Fang, X. (2018) · Cancers · doi:10.3390/cancers11010033 · Cited by 145
Chang, Y., Hsu, Y., Liu, C., Huang, S., Hu, M., & Cheng, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089563 · Cited by 145
The P2X7 receptor is a key modulator of aerobic glycolysis
Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D., & Virgilio, F. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.105 · Cited by 157
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
Kowalik, M. A., Columbano, A., & Perra, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00087 · Cited by 152
The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
Prochownik, E. V., & Wang, H. (2021) · Cells · doi:10.3390/cells10040762 · Cited by 150
Lin, Z., Li, J., Zhang, J., Feng, W., Lu, J., Ma, X., Ding, W., Ouyang, S., Lu, J., Yue, P., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3059 · Cited by 148
Bellone, M., Calcinotto, A., Filipazzi, P., Milito, A. D., Fais, S., & Rivoltini, L. (2012) · OncoImmunology · doi:10.4161/onci.22058 · Cited by 144
Stimuli-responsive polymers for anti-cancer drug delivery
Cheng, W., Gu, L., Ren, W., & Liu, Y. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.05.050 · Cited by 144
Sanchez, W. Y., McGee, S. L., Connor, T., Mottram, B. M., Wilkinson, A., Whitehead, J. P., Vučković, S., & Catley, L. P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.120 · Cited by 144
Metabolic Connections during Apoptotic Cell Engulfment
Han, C. Z., & Ravichandran, K. S. (2011) · Cell · doi:10.1016/j.cell.2011.12.006 · Cited by 149
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 144
Implications of reactive oxygen species on cancer formation and its treatment
Shah, M. A., & Rogoff, H. A. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.05.002 · Cited by 156
NAD+ salvage pathway in cancer metabolism and therapy
Kennedy, B. E., Sharif, T., Martell, E., Dai, C., Kim, Y., Lee, P. W. K., & Gujar, S. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.027 · Cited by 149
Nicotinamide metabolism regulates glioblastoma stem cell maintenance
Jung, J., Kim, L. J. Y., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90019 · Cited by 145
Lysine Acetylation Activates 6-Phosphogluconate Dehydrogenase to Promote Tumor Growth
Shan, C., Elf, S., Ji, Q., Kang, H., Zhou, L., Hitosugi, T., Jin, L., Lin, R., Zhang, L., Seo, J. H., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.020 · Cited by 142
Zacksenhaus, E., Shrestha, M., Liu, J. C., Vorobieva, I., Chung, P. E. D., Ju, Y., Nir, U., & Jiang, Z. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.002 · Cited by 143
The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells
Masgras, I., Sànchez‐Martìn, C., Colombo, G., & Rasola, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00058 · Cited by 143
Ganapathy‐Kanniappan, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.04.002 · Cited by 144
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 147
Hua, F., Li, K., Yu, J.-J., Lv, X.-X., Yan, J., Zhang, X.-W., Sun, W., Lin, H., Shang, S., Wang, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8951 · Cited by 141
Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis
Kamarajugadda, S., Cai, Q., Chen, H., Nayak, S., Zhu, J., He, M., Jin, Y., Zhang, Y., Ai, L., Martin, S. S., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.20 · Cited by 139
Regulation and roles of bicarbonate transporters in cancer
Gorbatenko, A., Olesen, C. W., Boedtkjer, E., & Pedersen, S. F. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00130 · Cited by 140
Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenols
Domenico, F. D., Foppoli, C., Coccia, R., & Marzia Perluigi, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.005 · Cited by 140
A Versatile Pt‐Based Core–Shell Nanoplatform as a Nanofactory for Enhanced Tumor Therapy
Wang, X., Zeng, J., Zhang, M., Zeng, X., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801783 · Cited by 139
Lussier, F., Missirlis, D., Spatz, J. P., & Masson, J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07024 · Cited by 140
Yousefi, H., Vatanmakanian, M., Mahdiannasser, M., Mashouri, L., Alahari, N. V., Monjezi, M. R., Ilbeigi, S., & Alahari, S. K. (2021) · Oncogene · doi:10.1038/s41388-020-01588-2 · Cited by 146
Phillips, C. M., Zatarain, J. R., Nicholls, M. E., Porter, C., Widen, S. G., Thanki, K., Johnson, P., Jawad, M. U., Moyer, M. P., Randall, J. W., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3480 · Cited by 139
Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
Justus, C., Sanderlin, E. J., & Yang, L. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511055 · Cited by 139
Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer
Zou, P., Xia, Y., Ji, J., Chen, W., Zhang, J., Chen, X., Rajamanickam, V., Chen, G., Wang, Z., Chen, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.058 · Cited by 140
Kouidhi, S., Elgaaïed, A. B., & Chouaïb, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00270 · Cited by 145
Correia, C., Koshkin, A., Duarte, P., Hu, D., Carido, M., Sebastião, M. J., Gomes‐Alves, P., Elliott, D. A., Domian, I. J., Teixeira, A. P., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26504 · Cited by 139
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 141
Li, R., Peng, F., Cai, J., Yang, D., & Zhang, P. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.06.003 · Cited by 142
Granlund, K. L., Tee, S.-S., Vargas, H. A., Lyashchenko, S. K., Reznik, E., Fine, S., Laudone, V., Eastham, J. A., Touijer, K. A., Reuter, V. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.024 · Cited by 138
Biology of Glucose Transport in the Mammary Gland
Zhao, F. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9310-8 · Cited by 138
Bezan, A., Mrsic, E., Krieger, D. A., Stojaković, T., Pummer, K., Zigeuner, R. E., Hutterer, G. C., & Pichler, M. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.01.083 · Cited by 138
The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition
Barriga, E. H., Maxwell, P. H., Reyes, A. E., & Mayor, R. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201212100 · Cited by 139
Reconstruction of Tissue-Specific Metabolic Networks Using CORDA
Schultz, A., & Qutub, A. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004808 · Cited by 140
The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer
Fitzgerald, G., Soro-Arnáiz, I., & Bock, K. D. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00100 · Cited by 137
The many faces of Janus kinase
Seavey, M. M., & Dobrzański, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.024 · Cited by 136
Sun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D. P., WILSON, C. A., Zhuang, G., Gao, M., Liu, P. J., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 134
How theTP53Family ProteinsTP63andTP73Contribute to Tumorigenesis: Regulators and Effectors
Candi, E., Agostini, M., Melino, G., & Bernassola, F. (2014) · Human Mutation · doi:10.1002/humu.22523 · Cited by 137
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 143
mTORC2 in the center of cancer metabolic reprogramming
Masui, K., Cavenee, W. K., & Mischel, P. S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.04.002 · Cited by 140
Mitochondria and the hallmarks of cancer
Giampazolias, E., & Tait, S. W. G. (2015) · FEBS Journal · doi:10.1111/febs.13603 · Cited by 144
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010189 · Cited by 139
Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression
Yang, B., Zhang, L., Cao, Y., Chen, S., Cao, J., Wu, D., Chen, J., Xiong, H., Pan, Z., Qiu, F., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0722-8 · Cited by 136
Xiang, L., Xu, X., Zhang, S., Cai, D., & Dai, X. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.001 · Cited by 138
Fu, X., Cui, J., Meng, X., Jiang, P., Zheng, Q., Zhao, W., & Chen, X. (2021) · Oncology Reports · doi:10.3892/or.2021.7933 · Cited by 138
Translational control of cell growth and malignancy by the CPEBs
D’Ambrogio, A., Nagaoka, K., & Richter, J. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3485 · Cited by 133
Biological insights through nontargeted metabolomics
Sévin, D. C., Kuehne, A., Zamboni, N., & Sauer, U. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.001 · Cited by 141
Emergence of spatial structure in the tumor microenvironment due to the Warburg effect
Carmona‐Fontaine, C., Bucci, V., Akkari, L., Déforet, M., Joyce, J. A., & Xavier, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311939110 · Cited by 140
Targeting metabolic reprogramming in KRAS-driven cancers
Kawada, K., Toda, K., & Sakai, Y. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1156-4 · Cited by 140
Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics
Shoshan‐Barmatz, V., Krelin, Y., Shteinfer‐Kuzmine, A., & Arif, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00154 · Cited by 135
Organic Bioelectronic Devices for Metabolite Sensing
Koklu, A., Ohayon, D., Wustoni, S., Druet, V., Saleh, A., & Inal, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00395 · Cited by 138
Cai, R., Ren, J., Guo, M., Wei, T., Liu, Y., Xie, C., Zhang, P., Guo, Z., Chetwynd, A. J., Ke, P. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200363119 · Cited by 137
Effects of Exercise on Tumor Physiology and Metabolism
Pedersen, L., Christensen, J. F., & Højman, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000096 · Cited by 142
Metabolism addiction in pancreatic cancer
Blum, R., & Kloog, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.38 · Cited by 138
Role of hypoxia in the tumor microenvironment and targeted therapy
Chen, G., Wu, K., Li, H., Xia, D., & He, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.961637 · Cited by 148
Germline BAP1 mutations induce a Warburg effect
Bononi, A., Yang, H., Giorgi, C., Patergnani, S., Pellegrini, L., Su, M., Xie, G., Signorato, V., Pastorino, S., Morris, P., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.95 · Cited by 133
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Yan, M., Gingras, M., Dunlop, E. A., Nouët, Y., Dupuy, F., Jalali, Z., Possik, E., Coull, B. J., Kharitidi, D., Dydensborg, A. B., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71749 · Cited by 141
Samec, M., Líšková, A., Koklesová, L., Samuel, S. M., Zhai, K., Buhrmann, C., Varghese, E., Abotaleb, M., Qaradakhi, T., Zulli, A., et al. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00217-y · Cited by 132
Diers, A. R., Broniowska, K. A., Chang, C.-F., & Hogg, N. (2012) · Biochemical Journal · doi:10.1042/bj20120294 · Cited by 133
Rodenhizer, D., Gaude, E., Cojocari, D., Mahadevan, R., Frezza, C., Wouters, B. G., & McGuigan, A. P. (2016) · Nature Materials · doi:10.1038/nmat4482 · Cited by 132
Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention
Zhang, Y., & Yang, J.-M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.22958 · Cited by 132
Gatto, F., Nookaew, I., & Nielsen, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319196111 · Cited by 132
The G0/G1 switch gene 2 (G0S2): Regulating metabolism and beyond
Heckmann, B. L., Zhang, X., Xie, X., & Liu, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.016 · Cited by 133
Cheng, G., Zielonka, J., McAllister, D. M., Mackinnon, A. C., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-285 · Cited by 132
Metabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., Garcı́a-Prieto, C., & Huang, P. (2011) · 癌症:英文版 · doi:10.5732/cjc.011.10267 · Cited by 137
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo
Venkatanarayan, A., Raulji, P., Norton, W., Chakravarti, D., Coarfa, C., Su, X., Sandur, S. K., Ramirez, M. S., Lee, J., Kingsley, C. V., et al. (2014) · Nature · doi:10.1038/nature13910 · Cited by 132
Metabolic regulation by SIRT3: implications for tumorigenesis
Finley, L. W. S., & Haigis, M. C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.004 · Cited by 134
The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease
Shanware, N. P., Bray, K., & Abraham, R. T. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134717 · Cited by 136
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
Bhatia, A., & Kumar, Y. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.865519 · Cited by 136
Wong, T. L., Ng, K. Y., Tan, K. V., Chan, L.-H., Zhou, L., Che, N., Hoo, R. L. C., Lee, T. K., Richard, S., Lo, C. M., et al. (2019) · Hepatology · doi:10.1002/hep.30923 · Cited by 130
Zhou, Y., Zhai, Z., Yao, Y., Stant, J. C., Landrum, S. L., Bortner, M. J., Frazier, C. E., & Edgar, K. J. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120213 · Cited by 131
Metadata
- Authors
- Cairns, R. A., Harris, I. S., & Mak, T. W.
- Corresponding author
- Mak, Tak W.
- Venue
- Nature Reviews Cancer
- Published
- 2011-01-24
- Volume
- 11
- Issue
- 2
- Pages
- 85-95
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028897202
- Semantic Scholar
- 9d36b5b10983f1aa90a9d9d5a7bcffe671b38257
- Cited by
- 4,744
- References
- 142
- Citations by year
- 2026: 95 · 2025: 192 · 2024: 234 · 2023: 276 · 2022: 293 · 2021: 418 · 2020: 423 · 2019: 386 · 2018: 386 · 2017: 414 · 2016: 399 · 2015: 387 · 2014: 318 · 2013: 251 · 2012: 192
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- cancer metabolism, Warburg effect, redox homeostasis, tumor microenvironment, carcinogenesis, central metabolic pathways
- MeSH terms
- Cell Transformation, Neoplastic, Humans, Neoplasms, Oxidation-Reduction, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Intracellular Signaling Peptides and Proteins, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review